Summary
Virus-mediated gene transfer shows great potential as a therapeutic strategy for the management of various inherited and acquired human diseases. Among the current viral vectors, adeno-associated virus (AAV) has become the vector of choice for numerous gene therapy applications. As AAV-based vectors approach the clinic, the need for scalable methods of production and purification is steadily increasing. In this chapter, we present a column chromatography-based protocol for the purification of recombinant AAV type 1 (AAV-1) to near homogeneity. The protocol, which can be completed within one working day, employs three major purification steps: (1) polyethylene glycol-mediated vector precipitation, (2) anion-exchange chromatography, and (3) gel filtration chromatography. This method provides a basic strategy, or “platform,” that can be adapted to the purification of other recombinant AAV vector serotypes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hoggan, M. D. (1970) Adenovirus associated viruses. Prog. Med. Virol. 12, 211–239.
Berns, K. I., and Bohenzky, R. A. (1987) Adeno-associated viruses: an update. Adv. Virus Res. 32, 243–306.
Berns, K. I., and Linden, R. M. (1995) The cryptic life style of adeno-associated virus. Bioessays 17, 237–245.
Smith, R. H., and Kotin, R. M. (2002) Adeno-associated virus, in Mobile DNA II (Craig, N. L., Craigie, R., Gellert, M., and Lambowitz, A., eds.), American Society for Microbiology, Washington, D. C., pp. 905–923.
Kronenberg, S., Kleinschmidt, J. A., and Bottcher, B. (2001) Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids. EMBO Rep. 2, 997–1002.
Walters, R. W., Agbandje-McKenna, M., Bowman, V. D., Moninger, T. O., Olson, N. H., Seiler, M., Chiorini, J. A., Baker, T. S., and Zabner, J. (2004) Structure of adeno-associated virus serotype 5. J. Virol. 78, 3361–3371.
Xie, Q, Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., and Chapman, M. S. (2002) The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. U. S. A. 99, 10405–10410.
Auricchio, A., O’Connor, E., Hildinger, M., and Wilson, J. M. (2001) A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors. Mol. Ther. 4, 372–374.
Auricchio, A., Hildinger, M., O’Connor, E., Gao, G.-P., and Wilson, J. M. (2001) Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12, 71–76.
Blouin, V., Brument, N., Toublanc, E., Raimbaud, I., Moullier, P., and Salvetti, A. (2004) Improving rAAV production and purification: towards the definition of a scaleable process. J. Gene Med. 6, S223–S228.
Brument, N., Morenweiser, R., Blouin, V., Toublanc, E., Raimbaud, I., Cherel, Y., Folliot, S., Gaden, F., Boulanger, P., Kroner-Lux, G., Moullier, P., Rolling, F., and Salvetti, A. (2002) A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol. Ther. 6, 678–686.
Clark, K. R., Liu, X., McGrath, J. P., and Johnson, P. R. (1999) Highly purified adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10, 1031–1039.
Davidoff, A. M., Ng, C. Y. C., Sleep, S., Gray, J., Azam, S., Zhao, Y., McIntosh, J. H., Karimipoor, M., and Nathwani, A. C. (2004) Purification of recombinant adeno-associated virus type 8 by ion exchange chromatography generates clinical grade vector stock. J. Virol. Methods 121, 209–215.
Gao, G., Qu, G., Burnham, M. S., Huang, J., Chirmule, N., Joshi, B., Yu, Q.-C., Marsh, J. A., Conceicao, C. M., and Wilson, J. M. (2000) Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum. Gene Ther. 11, 2079–2091.
Ioffe, E., and Burova, E. (2005) Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications. Gene Ther. 12, S5–S17.
Kaludov, N., Handelman, B., and Chiorini, J. A. (2002) Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum. Gene Ther. 13, 1235–1243.
O’Riordan, C. R., Lachapelle, Vincent, K. A., and Wadsworth, S. C. (2000) Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV). J. Gene Med. 2, 444–454.
Smith, R. H., Ding, C., and Kotin, R. M. (2003) Serum-free production and column purification of adeno-associated virus type 5. J. Virol. Methods 114, 115–124.
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R., J., and Muzyczka, N. (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973–985.
Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T. J., Jr., Chiodo, V. A., Phillipsberg, T., Muzyczka, N., Hauswirth, W., W., Flotte, T. R., Byrne, B. J., and Snyder, R. O. (2002) Production and purification of serotypes 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28, 158–167.
Atha, D. H., and Ingham, K. C. (1981) Mechanism of precipitation of proteins by polyethylene glycols. J. Biol. Chem. 256, 12108–12117.
Xie, Q., Hare, J., Turnigan, J., and Chapman, M. S. (2004) Large-scale production, purification and crystallization of wild-type adeno-associated virus-2. J. Virol. Methods 122, 17–27.
Acknowledgements
This research was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health. We thank Sylvain Cecchini for critical review of the draft manuscript.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Smith, R.H., Yang, L., Kotin, R.M. (2008). Chromatography-Based Purification of Adeno-Associated Virus. In: Le Doux, J.M. (eds) Gene Therapy Protocols. Methods in Molecular Biology™, vol 434. Humana Press. https://doi.org/10.1007/978-1-60327-248-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-60327-248-3_4
Publisher Name: Humana Press
Print ISBN: 978-1-60327-247-6
Online ISBN: 978-1-60327-248-3
eBook Packages: Springer Protocols